Chandigarh

Chemsroot Pharmaceutical LLP

GST04**********1ZBTrustSEAL Mobile E-Mail 5 yrs

★★★★★★★★★★
 4.4 (60)
89% Response Rate
Contact Supplier
  • Legal Status of Firm

    Partnership

  • GST Registration Date

    Nov 2021

  • Annual Turnover

    1.5 - 5 Cr

  • Indiamart Member Since

    Apr 2021

Nutraceutical Third Party Manufacturing

₹ 450/BoxProduct Brochure

Service ModeOffline
Service Duration15 Days
Service LocationPan India
Payment ModeOnline/Offline
Service TypeNutraceutical Third Party Manufacturing
AvailabilityIn Stock
We are engaged in offering a wide range of  quality products  to our clients. Our range of all products is widely appreciated by our clients.

Find products similar to Nutraceutical Third Party Manufacturing

Find related categories

Shipping Information

PriceExcluding all taxes
ShippingAs per delivery location

Product Image

Nutraceutical Third Party Manufacturing-1Nutraceutical Third Party Manufacturing-2Nutraceutical Third Party Manufacturing-3

About the Company

GST Registration Date
Nov 2021
Legal Status of Firm
Partnership
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
Apr 2021
GST
04**********1ZB
Import Export Code (IEC)
*******63F

Established in the year of 2021, we“Chemsroot Pharmaceutical LLP” are Trader,Wholesaler And Distributor of Pharmaceutical Tablets, Pcd Pharma Franchise, Third Party Manufacturing, Derma Pcd Pharma, Pharmaceutical Capsules,Allopathic Pcd Pharma Franchise,Pharmaceutical Injections,Pharmaceutical Syrup,Ointements Third Party Manufacturing etc We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our (CEO) “Mr.Abhishek” whose continual backing and direction have been useful to us for attaining exponential development in the current market